These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16194710)

  • 21. [Primary upper urinary tract tumors and subsequent location in the bladder].
    Azémar MD; Audouin M; Revaux A; Misraï V; Comperat E; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer.
    Ehdaie B; Stukenborg GJ; Theodorescu D
    J Urol; 2009 Oct; 182(4):1482-7. PubMed ID: 19683766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
    Stein JP; Penson DF; Wu SD; Skinner DG
    J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder cancer following upper tract urothelial carcinoma.
    Kauffman EC; Raman JD
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):75-85. PubMed ID: 18095885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
    J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer.
    Black PC; Brown GA; Dinney CP
    J Clin Oncol; 2006 Dec; 24(35):5528-35. PubMed ID: 17158538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion.
    Andius P; Johansson SL; Holmäng S
    Urology; 2007 Oct; 70(4):758-62. PubMed ID: 17991551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
    Kakizoe T; Mucci LA; Albertsen PC; Droller MJ
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):191-212. PubMed ID: 18815934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
    Shariat SF; Ashfaq R; Karakiewicz PI; Saeedi O; Sagalowsky AI; Lotan Y
    Cancer; 2007 Mar; 109(6):1106-13. PubMed ID: 17311310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting death receptors in bladder, prostate and renal cancer.
    O'Kane HF; Watson CJ; Johnston SR; Petak I; Watson RW; Williamson KE
    J Urol; 2006 Feb; 175(2):432-8. PubMed ID: 16406966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?
    Scosyrev E; Yao J; Messing E
    Urology; 2009 Apr; 73(4):822-7. PubMed ID: 19193403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.